Recent Analyst Forecasts and Stock Ratings
4D Molecular Therapeutics, Inc. FAQ's
4D Molecular Therapeutics, Inc. has been rated by research analysts at Morgan Stanley, BMO Capital, Loop Capital Markets, H.C. Wainwright, RBC Capital, Barclays in the past 90 days.